Citigroup’s COSCIENS Biopharma CSCI Stock Holding History
Bought
Maintained
Sold
Other funds holding CSCI
Citigroup's CSCI Position: Q1 2025 in Review
Citigroup sold out of COSCIENS Biopharma (CSCI) in Q1 2025, closing a stake of 902 shares — an estimated $2.42K sold.
Citigroup first reported a position in CSCI in Q1 2014 and held it in 20 quarters. The position peaked at $8K in Q1 2014. 15 funds tracked by Wall St. Rank hold CSCI as of Q1 2025.
- Citigroup reported no remaining COSCIENS Biopharma position as of Q1 2025 after selling out during the quarter.
- Citigroup sold 902 COSCIENS Biopharma shares in Q1 2025, an estimated $2.42K.
- Citigroup first reported a position in COSCIENS Biopharma in Q1 2014 and held it in 20 quarters.
- Citigroup's COSCIENS Biopharma position peaked at $8K in Q1 2014.
- 15 funds tracked by Wall St. Rank held COSCIENS Biopharma as of Q1 2025.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.